<p>Fold-changes in BDNF or TrkB mRNA against sham-control detected by real-time PCR (A,C), temporal changes in tissue levels of BDNF detected by ELISA (B) or TrkB detected by Western blot analysis (D) in tissues collected from bilateral RVLM 180 min (A,C,D) or 1, 2 or 3 h (B) after microinjection of KA (0.5 nmol) or PBS into the left hippocampal CA3 subfield. Values are mean ± SEM of triplicate analyses from 5–6 animals per experimental group. *<i>P</i><0.05 versus sham-control or PBS group in the post hoc Scheffé multiple-range test.</p
<p>(A) Western blot detection in hTERT-RPE1 cells of phosphorylated TRKB (pTRKB) and unphosphorylate...
<p>(<b>A, B</b>) Quantification of phosphorylated (p) forms of TrkB, Akt, and ERK in primary cortica...
<p>(A) PKMζ protein level in cortex and hippocampus of BDNF KO and WT littermates. At postnatal day ...
<p>Fold-changes in BDNF (A) or TrkB (B) mRNA against sham-control detected by real-time PCR in tissu...
<p>Illustrative gels or summary of changes in NOS II detected by Western blot analysis (A) or nitrot...
(A, C) RT-PCR quantification of BDNF (A) and TrkB (C) transcripts in the mouse hippocampus obtained ...
<p>Temporal changes in MAP (A), power density of the BLF component (B), HR (C) or BRS (D) after micr...
<p>Temporal changes in MAP (A), power density of the BLF component (B), HR (C) or BRS (D) after micr...
<p>(a) Representative blots of experiments showing age-dependent modification of BDNF-induced (50 ng...
<p>Illustrative gels or summary of fold changes in angiotensin receptor subtype 1 (AT1R) or subtype ...
<p>Western blot analyses of cells treated with peptides B-5, B-4 and B-3, or with BDNF, or vehicle f...
<p>(A) Western blots of BDNF, and total TrkB, of hippocampal cells treated with 0.1 µM peptide B-5 o...
<p>(<b>A</b>) Gene expression for <i>Bdnf</i> and <i>Trkb</i> in control (CTL, open bars) and HPRT k...
<p>(A) Schematic of the experimental design for sample collection. (B) Temporal and spatial changes ...
<p>(a) P60 mice were pretreated acutely with imipramine (Imi; 30 mg/kg i.p., 60 min) or saline (Sal)...
<p>(A) Western blot detection in hTERT-RPE1 cells of phosphorylated TRKB (pTRKB) and unphosphorylate...
<p>(<b>A, B</b>) Quantification of phosphorylated (p) forms of TrkB, Akt, and ERK in primary cortica...
<p>(A) PKMζ protein level in cortex and hippocampus of BDNF KO and WT littermates. At postnatal day ...
<p>Fold-changes in BDNF (A) or TrkB (B) mRNA against sham-control detected by real-time PCR in tissu...
<p>Illustrative gels or summary of changes in NOS II detected by Western blot analysis (A) or nitrot...
(A, C) RT-PCR quantification of BDNF (A) and TrkB (C) transcripts in the mouse hippocampus obtained ...
<p>Temporal changes in MAP (A), power density of the BLF component (B), HR (C) or BRS (D) after micr...
<p>Temporal changes in MAP (A), power density of the BLF component (B), HR (C) or BRS (D) after micr...
<p>(a) Representative blots of experiments showing age-dependent modification of BDNF-induced (50 ng...
<p>Illustrative gels or summary of fold changes in angiotensin receptor subtype 1 (AT1R) or subtype ...
<p>Western blot analyses of cells treated with peptides B-5, B-4 and B-3, or with BDNF, or vehicle f...
<p>(A) Western blots of BDNF, and total TrkB, of hippocampal cells treated with 0.1 µM peptide B-5 o...
<p>(<b>A</b>) Gene expression for <i>Bdnf</i> and <i>Trkb</i> in control (CTL, open bars) and HPRT k...
<p>(A) Schematic of the experimental design for sample collection. (B) Temporal and spatial changes ...
<p>(a) P60 mice were pretreated acutely with imipramine (Imi; 30 mg/kg i.p., 60 min) or saline (Sal)...
<p>(A) Western blot detection in hTERT-RPE1 cells of phosphorylated TRKB (pTRKB) and unphosphorylate...
<p>(<b>A, B</b>) Quantification of phosphorylated (p) forms of TrkB, Akt, and ERK in primary cortica...
<p>(A) PKMζ protein level in cortex and hippocampus of BDNF KO and WT littermates. At postnatal day ...